Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.

Biotechnology

Concarlo Holdings

Concarlo Holdings' headquarters in NY, United States

Stacy Blain

Krishna Allamneni

Grace Chen

Keren Paz

Neal Rosen

Daniel Heller

Gary Schwartz

Geoffrey Shapiro

Jay Campbell

Mike Harrington

Arthur Klausner

Robert Devita

Jason Mraz

Andrew Koff

The Scientific and Business Advisors team at Concarlo Holdings provides critical expertise in both the scientific and business aspects of precision medicine in oncology. This multidisciplinary group collaborates to drive research and development initiatives, ensuring innovative approaches to targeting the p27Kip1 pathway while also strategizing for market entry, partnership opportunities, and funding to support the company's growth and mission in cancer treatment.

Scientific and Business Advisors

The Leadership Team at Concarlo Holdings oversees the strategic direction and operational management of the company, driving innovation in precision medicine for oncology. Comprising seasoned experts, including the Chief Development Officer and co-founders, they collaborate to align research initiatives with clinical objectives, ensuring the successful development and commercialization of therapies targeting the p27Kip1 pathway.

Leadership Team

Concarlo Holdings

Org chart

Board & advisors

Teams

Scientific and Business Advisors

Leadership Team

Offices

Concarlo Holdings

Org chart

Board & advisors

Teams

Scientific and Business Advisors

Leadership Team

Offices

Related companies